Cancer researchers focused on improving the success of cancer immunotherapies introduced a new tool in a Yale study published ...

Bioengineers at the University of California San Diego have developed a powerful new technology that can map the entire ...

First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Doses of ARV-102, a PROTAC LRRK2 Degrader, in Healthy Participants Date & Time : Oct.

At first glance, plants may seem passive – but beneath their stillness lies a world of complexity and constant activity.

Oral presentation highlights safe, robust reduction in apoC-III and triglycerides by MB-111, paving the way to the clinic in 2026.

High IL1RAP protein expression on tumor cells is linked to poor survival in PDAC patients treated with chemotherapy, while this patient group has the longest survival when treated with nadunolimab in ...

VANCOUVER, Washington, Sept. 30, 2025 (GLOBE NEWSWIRE) -- ...

Objective Inflammation and repair responses may be involved in atherosclerosis in rheumatoid arthritis (RA), although ...

Loopworm recently announced a Series A funding round to commercialize its proprietary recombinant protein platform, the ...

In a development that could help protect one of the world's most beloved agricultural commodities, a research team at Penn ...

Angel Yeast remains dedicated to advancing yeast protein research and product development, creating healthy and great-tasting solutions for consumers worldwide. The company will also continue ...